Ken Griffin Clear Point Neuro, Inc. Put Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$5.3 - $13.18 $120,310 - $299,186	22,700 Added 667.65%	26,100 $292,000
Q2 2024 Aug 14, 2024	SELL	$5.25 - $6.73 $9,450 - $12,114	-1,800 Reduced 34.62%	3,400 $18,000
Q1 2024 May 15, 2024	BUY	$6.03 - $7.86 $18,693 - $24,366	3,100 Added 147.62%	5,200 $35,000
Q4 2023 Feb 14, 2024	SELL	$4.46 - $7.07 $10,704 - $16,968	-2,400 Reduced 53.33%	2,100 $14,000
Q3 2023 Nov 14, 2023	SELL	$5.01 - $7.09 $64,128 - $90,752	-12,800 Reduced 73.99%	4,500 $22,000
Q2 2023 Aug 14, 2023	SELL	$6.54 - $10.58 $92,214 - $149,178	-14,100 Reduced 44.9%	17,300 $125,000
Q1 2023 May 15, 2023	SELL	$7.33 - $10.63 $49,111 - $71,221	-6,700 Reduced 17.59%	31,400 $265,000
Q4 2022 Feb 14, 2023	SELL	$7.7 - $11.21 $749,980 - $1.09 Million	-97,400 Reduced 71.88%	38,100 $322,000
Q3 2022 Nov 14, 2022	BUY	$9.82 - $16.49 $1.18 Million - $1.99 Million	120,400 Added 797.35%	135,500 $1.4 Million

6.81M

84.3K

56.7K

Ticker CLPT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,488,300
Market Cap $400M
Description
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.